Michael Higgins
Managing Director, Biopharmaceuticals Equity Research
Ladenburg Thalmann & Co. Inc.
Dr Richard Alm
Director of Alliances
CARB-X / Consultant, WHO
Richard joined CARB-X as an Alliance Director following almost 20 years in large pharma Infection R&D teams followed by 4 years at a small antibacterial biotech company. He has supported the progression of small molecule compounds from discovery through to late-stage clinical development. He obtained his PhD in molecular microbiology from the University of Adelaide, and prior to joining industry he held two post-doctoral positions in the AMR area, one in Australia and one in Canada. Richard is also a consultant on the Global Action Plan on Antimicrobial Resistance for the World Health Organization (WHO).
Rima Raouda
Tech Researcher & Content Director
Independent
Davis Sawyer
Co-Founder and CPO
Deeplite